A detailed history of Royal Bank Of Canada transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,087 shares of ICCM stock, worth $1,217. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,087
Previous 1,087 -0.0%
Holding current value
$1,217
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.74 - $1.35 $296 - $540
400 Added 58.22%
1,087 $0
Q1 2024

Nov 05, 2024

SELL
$1.16 - $1.48 $463 - $592
-400 Reduced 36.8%
687 $0
Q4 2022

Feb 14, 2023

BUY
$0.94 - $2.6 $175 - $486
187 Added 37.4%
687 $1,000
Q3 2022

Nov 14, 2022

SELL
$1.12 - $2.03 $209 - $379
-187 Reduced 27.22%
500 $1,000
Q4 2021

Feb 14, 2022

BUY
$2.73 - $8.7 $682 - $2,175
250 Added 57.21%
687 $2,000
Q3 2021

Nov 15, 2021

BUY
$8.61 - $11.33 $3,762 - $4,951
437 New
437 $4,000

Others Institutions Holding ICCM

About IceCure Medical Ltd.


  • Ticker ICCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,835,600
  • Market Cap $41.3M
  • Description
  • IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
More about ICCM
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.